Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
52
NCT04373785
NG101m Adjuvant Therapy in Glioblastoma Patients
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 1, 2027
Completion: Dec 31, 2030